By heparin blocking the exosomal binding to cellular heparan sulfate proteoglycans, the adhesion and uptake of exosomes of all three ALL cell lines were reduced to 37%, 5% and 21% for SD1, Nalm-6 and P12 exosomes, respectively. This evidence concerns the gene CD44 and acute lymphoblastic leukemia.